DocSym
β
Searchsearch
Search
(Y44.1) Vitamin b 12 , folic acid and other anti-megaloblastic-anaemia preparations
More details coming soon
178 229 in individuals diagnosis vitamin b 12 , folic acid and other anti-megaloblastic-anaemia preparations confirmed
15 706 deaths with diagnosis vitamin b 12 , folic acid and other anti-megaloblastic-anaemia preparations
9% mortality rate associated with the disease vitamin b 12 , folic acid and other anti-megaloblastic-anaemia preparations
Diagnosis vitamin b 12 , folic acid and other anti-megaloblastic-anaemia preparations is diagnosed Women are 11.62% more likely than Men
78 763
Men receive the diagnosis vitamin b 12 , folic acid and other anti-megaloblastic-anaemia preparations
8 102 (10.3 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
99 466
Women receive the diagnosis vitamin b 12 , folic acid and other anti-megaloblastic-anaemia preparations
7 604 (7.6 %)Died from this diagnosis.
Risk Group for the Disease vitamin b 12 , folic acid and other anti-megaloblastic-anaemia preparations - Men aged 75-79 and Women aged 80-84
In Men diagnosis is most often set at age 0-5, 15-19, 25-34, 40-94
Less common in men the disease occurs at Age 0-1, 5-14, 20-24, 35-39, 95+Less common in women the disease occurs at Age 5-29, 40-49, 95+
In Women diagnosis is most often set at age 0-5, 30-39, 50-94
Disease Features vitamin b 12 , folic acid and other anti-megaloblastic-anaemia preparations
Absence or low individual and public risk
Vitamin b 12 , folic acid and other anti-megaloblastic-anaemia preparations - what does this mean
Vitamin b12, folic acid and other anti-megaloblastic-anaemia preparations are used to treat megaloblastic anemia, a condition caused by a deficiency of vitamin b12 or folate. this deficiency can lead to a decrease in red blood cell production, causing anemia. treatment with these preparations helps to restore normal red blood cell production and alleviate the symptoms of anemia.
What happens during the disease - vitamin b 12 , folic acid and other anti-megaloblastic-anaemia preparations
The pathogenesis of vitamin b 12 , folic acid and other anti-megaloblastic-anaemia preparations is that they are used to treat deficiencies in vitamin b 12 and folic acid, which can lead to megaloblastic anaemia. these deficiencies can be caused by various factors including malabsorption, dietary deficiency, and certain medications. the preparations help to replenish the necessary vitamins and minerals in the body, which helps to restore normal red blood cell production and improve the symptoms of the anaemia.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Complete Blood Count (CBC)
- Folate Level Test
- Vitamin B12 Level Test
- Bone Marrow Aspiration and Biopsy
- Serum Creatinine Test
- Urine Analysis
- Abdominal Ultrasound
- CT Scan
- MRI
- Vitamin B12, Folic Acid and other Anti-Megaloblastic-Anaemia Preparations
Treatment and Medical Assistance
Main goal of the treatment: Treating Megaloblastic Anemia
- Administer Vitamin B12 injections
- Prescribe oral or injectable folic acid supplements
- Prescribe anti-megaloblastic anemia medications
- Monitor red blood cell count to assess response to treatment
- Monitor blood levels of Vitamin B12 and folic acid to ensure adequate levels
- Provide dietary guidance to ensure adequate intake of B12 and folic acid
- Provide lifestyle advice to reduce stress and improve overall health
17 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Vitamin b 12 , folic acid and other anti-megaloblastic-anaemia preparations - Prevention
The best way to prevent megaloblastic anemia is to ensure an adequate intake of vitamin b12, folic acid and other anti-megaloblastic-anaemia preparations. this can be done through a balanced diet, supplementation, and regular monitoring of vitamin levels. additionally, individuals at risk should be screened regularly to ensure early diagnosis and treatment.